ACTICOAT Antimicrobial Barrier Dressings
Two-Week Challenge
Managing infected wounds?
Take two minutes now to help alter the course of infection with our challenge.
How the challenge works
Use ACTICOAT Dressings on wounds displaying signs and symptoms of infection, and after two weeks review. Underneath you see the basic streps of the ACTICOAT Two-Week Challenge.
If you are interested in taking part of this 2-week challenge, subscribe underneath and we'll guide you all the way with useful information and tools to get most out of it.
Why take the challenge?
Find a fast path to healing in just two weeks*5-8Given the cost, burden and patient impact of infected wounds, can wound infection be mastered in just two weeks? It’s unlikely… but you could find a route to help control wound infection using ACTICOAT Dressings on suitable patients.4,9-14
+ Fast Acting
ACTICOAT FLEX 3 Dressing rapidly kills bacteria in as little as 30 minutes.*1-6Early intervention with ACTICOAT FLEX Dressings has been shown to resolve infection rapidly - within 2 weeks in 60% of patients.†7,8
+ Broad spectrum efficiency
ACTICOAT FLEX Dressings are effective against over 150 pathogens. *9-13Use of ACTICOAT FLEX Dressings demonstrated a significant reduction in length of stay, along with estimated reductions in overall treatment cost per patient.§14
+ Sustained release of silver
ACTICOAT FLEX 3 Dressings use our Nanocrystalline silver technology which is designed to rapidly deliver silver to the wound and maintain it’s antimicrobial activity for up to three days 2-6,9,10
How ACTICOAT Dressings work
Choosing the right patients
The ACTICOAT Two-Week Challenge could highlight a path to help take control of infection 7,15-18 and help support antimicrobial stewardship, but identifying the right patients is crucial.
Following the principles of best practice, it has been shown that accurate decision-making, a fast response and effective treatment choices help improve patient outcomes.19 Use our infection management pathway to help identify suitable patients with wounds showing signs and symptoms of infection.
Additional resources
Disclaimers
*As demonstrated in vitro
† n=75
§ Compared to Aquacel Ag™, Mepilex Ag™ and SSD; USD 2017; LOS p<0.0001